Tuesday, August 01, 2006

Clinical Oncology Week & Women's Health Law Weekly

Apoptosis

Cancer apoptosis induced by novel microbial fermentation product

May 15th, 2006

Cancer apoptosis was induced by the anti-cancer activity of a novel microbial fermentation product. According to recent research from the People's Republic of China, "The possible anti-proliferation and cell death induction potential of a novel microbial fermentation extract named as oncogen XP-180 (or simply as XP-180) was tested on three human solid tumor carcinoma cell lines (non-small cell lung cancer A549, breast cancer MDA-MB231, liver adenocarcinoma SK-Hep1) and on the acute myelogenous leukaemia KG1a cell line. Anti-proliferative activity of XP-180 was observed on all of these cancer cell lines with comparable efficiency and in a dose-dependent manner."...

2 Comments:

Anonymous Anonymous said...

how effective is this product for IV stage non-small cell lung cancer? any statistic?

6:47 PM  
Blogger Matt said...

Hi,

Thanks for droping by and asking. I'm not the doctor to really answer that question at the moment. However, i can mail this question to the doctor and creator of Oncogen XP-180.

I will post the answer here once he replies. Could you specify more in detail so that Doctor Wong can give a better answer to that question.

I'm only an agent to a marketing company for Oncogen XP-180 to grant sole distributorship to anyone who are interested in getting the licence to sell in thier respective country(that has not been taken yet).

Please do drop by often for the updates and answer here.

Thank you.

3:17 AM  

Post a Comment

<< Home